Thrombosis

News

Drug for aHUS effective but expensive

AMSTERDAM—Eculizumab elicits “phenomenal” results in atypical hemolytic uremic syndrome (aHUS), according to two presentations given at the 17th...

News

FDA explains dabigatran dose approval

The medical community was surprised when the Food and Drug Administration (FDA) approved the higher dose of dabigatran and not the lower dose last...

Pages